Who Generates Higher Gross Profit? Regeneron Pharmaceuticals, Inc. or Walgreens Boots Alliance, Inc.

Comparing Gross Profits: Regeneron vs. Walgreens Boots Alliance

__timestampRegeneron Pharmaceuticals, Inc.Walgreens Boots Alliance, Inc.
Wednesday, January 1, 2014261453900021569000000
Thursday, January 1, 2015371101900026753000000
Friday, January 1, 2016456073300029874000000
Sunday, January 1, 2017547516600029162000000
Monday, January 1, 2018627670000030792000000
Tuesday, January 1, 2019708120000028159000000
Wednesday, January 1, 2020737720000026077000000
Friday, January 1, 20211363420000028067000000
Saturday, January 1, 20221061250000028266000000
Sunday, January 1, 20231130140000027072000000
Monday, January 1, 20241223150000026524000000
Loading chart...

In pursuit of knowledge

A Tale of Two Giants: Regeneron vs. Walgreens Boots Alliance

In the ever-evolving landscape of the pharmaceutical and retail sectors, two titans stand out: Regeneron Pharmaceuticals, Inc. and Walgreens Boots Alliance, Inc. Over the past decade, these companies have showcased their prowess in generating substantial gross profits. From 2014 to 2023, Walgreens consistently outperformed Regeneron, boasting gross profits that were approximately three to four times higher each year. For instance, in 2023, Walgreens achieved a gross profit of around $27 billion, while Regeneron reached approximately $11 billion. Despite Regeneron's impressive growth, Walgreens' dominance in the retail pharmacy sector has kept it ahead. However, Regeneron's rapid growth trajectory, with a 330% increase from 2014 to 2023, suggests a promising future. As we look forward, the missing data for 2024 leaves us anticipating how these industry leaders will continue to shape the market.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025